The Purpose of Study is to Evaluate the Safety, Pharmacokinetics and Anti-tumor Effects of CKD-702 in Patients With Advanced or Metastatic Non-small Cell Lung Cancer Who Failed to Standard Therapy
Clinical trial NCT04667975 · UNKNOWN
Trial details
- NCT number
- NCT04667975
- Sponsor
- Chong Kun Dang Pharmaceutical
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-05-21
- Primary completion
- 2021-08-15
- Enrollment
- 74
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.